Skip to content

The role of exercise training frequency in long-term blood pressure control

Understanding dose-response in isometric exercise training: the role of training frequency in long-term blood pressure control

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN62287921
Enrollment
118
Registered
2025-06-16
Start date
2020-01-21
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention of hypertension in normotensive to pre-hypertensive adults through isometric exercise training Circulatory System

Interventions

All participants are randomly assigned using stratified random allocation to one of five groups. During the first 4 weeks, all intervention groups complete isometric wall squat training three times pe

Sponsors

Canterbury Christ Church University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Male and female participants with normal to high-normal sBP (range 120-140 mmHg) 2. University staff and students from Canterbury Christ Church University and their associates via social media and word of mouth 3. Total weekly physical activity level below the 150 minutes of moderate physical activity per week, or specifically =600 MET-minutes, calculated as the sum of all light-intensity activities (light walking = 3.3 METs, light cycling = 3.0 METs, household work = 2.5 METs). Total MET-minutes were computed as MET × duration (min). To exclude structured exercise, any reported bout =4 METs lasting = 10 minutes (e.g. jogging and weight training) led to exclusion. 4. Free from any injuries or illnesses 5. Not taking any medication (or had previously taken any anti-hypertensive medication) 6. Non-smokers 7. Consumed less than 14 units of alcohol per week 8. Screening was conducted using a standard Physical Activity Readiness Questionnaire 9. Provided written informed consent

Exclusion criteria

Exclusion criteria: 1. Free from any injuries or illnesses 2. Not taking any medication (or had previously taken any anti-hypertensive medication) 3. Non-smokers 4. Consumed less than 14 units of alcohol per week

Design outcomes

Primary

MeasureTime frame
Resting systolic blood pressure (SBP) is measured using the Task Force® Monitor during a 5-minute seated continuous recording at baseline, week 4, and week 8

Secondary

MeasureTime frame
1. Mean arterial pressure (MAP) is calculated from continuous blood pressure data recorded by the Task Force® Monitor during a 5-minute seated period at baseline, week 4, and week 8 2. Diastolic blood pressure (DBP) is measured using the Task Force® Monitor during the same 5-minute seated recording at baseline, week 4, and week 8 3. Total peripheral resistance (TPR) is derived from concurrent blood pressure and cardiac output signals via the Task Force® Monitor during a 5-minute seated measurement at baseline, week 4, and week 8 4. Cardiac output (Q?) and stroke volume (SV) are recorded via impedance cardiography using the Task Force® Monitor during a 5-minute seated recording at baseline, week 4, and week 8 5. Heart rate variability (HRV) metrics (LF, HF, LFnu, HFnu, LF/HF ratio) are calculated from ECG data obtained via the Task Force® Monitor during the 5-minute seated period at baseline, week 4, and week 8 6. Baroreflex sensitivity (BRS) is assessed using sequence and spectral methods applied to the 5-minute continuous Task Force® Monitor data at baseline, week 4, and week 8

Countries

England, United Kingdom

Contacts

Public ContactJim Wiles
jim.wiles@canterbury.ac.uk+44 (0)1227 767700

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026